About Us

​Pathology Asia is committed to ensuring that healthcare professionals are well-informed when making choices that will shape medical decisions and health diagnoses. To this end, we provide decisive diagnostic information that supports decision-making to provide the best patient outcomes.

With leading medical diagnostic laboratories in Singapore, Malaysia, Vietnam, the Philippines, Indonesia and Australia; as well as a digital platform for healthcare providers, Pathology Asia aspires to be the foremost trusted diagnostics services provider in Southeast Asia and Australasia.

In line with our goal to become a fully integrated digital healthcare organization, Pathology Asia consolidates data with existing clinical pathways and flows to ensure interoperability resulting in a smoother clinical workflow. We focus on enhancing quality of care through improved patient engagement and monitoring, enabling cost-effective solutions and optimized workflows.

Our History

1995

  • Quest Laboratories established from the amalgamation of The Medical Laboratory, Health Medical and Quest Laboratories in Singapore.

1996

  • Innovative Diagnostics established as a subsidiary of Singhealth.
  • Gribbles Pathology begins operations in Malaysia.

2003

  • Gribbles becomes the first major private pathology laboratory in Malaysia to be accredited by NATA.

2008

  • Quest Laboratories accredited with ISO 15189 Singapore Laboratory Accreditation Scheme (SAC-SINGLAS) by the Singapore Accreditation Council (SAC).

2009

  • Safework Laboratories accredited by NATA in Australia.

2010

  • Clinipath is accredited by Standards Malaysia.

2011

  • Innovative Diagnostics changes ownership to a group of doctors and lab operators led by Dr. Chris Ting.
  • Quest's entry into Vietnam with a laboratory at Hanh Phuc Women & Children's Hospital in Ho Chi Minh City.

2012

  • Dr. Chris Ting founds Quantum Diagnostics in Malaysia.

2015

  • Innovative Diagnostics is the first multi-disciplinary private medical laboratory in Singapore to become a College of American Pathologists (CAP) accredited laboratory.

2016

  • Quest Laboratories becomes the only private independent full-service laboratory in Singapore to hold dual international accreditation (CAP and SINGLAS).
  • Innovative Diagnostics is recognized by the Westgard Sigma Verification Program - the first medical institution in Singapore to be so awarded.

2017

  • BioMark is founded.
  • GenomixLab recognised as the Best Advanced Genomics Laboratory at INPenang Awards 2017

2018

  • At the ASEAN Rice Bowl Startup Awards, Biomark wins the award for the Best Health Tech Startup in ASEAN.
  • Pathology Asia is founded with the acquisition of Gribbles Pathology, Quantum Diagnostics, Innovative Diagnostics and Quest Laboratories by TPG Capital.

2019

  • Pathology Asia acquires Safework Laboratories in Australia; and Clinipath in Malaysia.
  • Announcement of Merger of Innovative Diagnostics and Quest Laboratories in Singapore.

2020

  • GenomixLab becomes the only CAP-accredited genetic diagnostics lab in Malaysia.
  • Pathology Asia acquires Advanced Genomics, the parent company of GenomixLab; and BioMark.
  • GenomixLab wins the award for Advanced Genetic Centre Provider of the Year in the Asia-Pacific at the Global Health Asia-Pacific Awards.

2021

  • Innoquest Diagnostics Pte. Ltd. is officially launched from the merger of Innovative Diagnostics and Quest Laboratories in Singapore.
  • LifeStrands is founded and launched in Singapore.
  • Pathology Asia acquires Singapore Diagnostics in the Philippines and TissuPath in Australia.

2022

  • Gribbles Pathology receives College of American Pathologists (CAP) accreditation, becoming the only dual-accredited laboratory in Malaysia.
  • Gribbles Pathology is officially rebranded to Innoquest Pathology Sdn. Bhd.
  • Innoquest Indonesia is established in Jakarta, operating from a Core Lab in Kuningan.